↓ Skip to main content

July 2017 ENCALS statement on edaravone

Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, October 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 1,115)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
25 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
89 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
July 2017 ENCALS statement on edaravone
Published in
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, October 2017
DOI 10.1080/21678421.2017.1369125
Pubmed ID
Authors

Ammar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, Adriano Chio, Philippe Corcia, Philippe Couratier, Olof Danielsson, Mamede de Carvalho, Claude Desnuelle, Torsten Grehl, Julian Grosskreutz, Trygve Holmøy, Caroline Ingre, Merete Karlsborg, Grethe Kleveland, Jan Christoph Koch, Blaz Koritnik, Magdalena KuzmaKozakiewicz, Hannu Laaksovirta, Albert Ludolph, Christopher McDermott, Thomas Meyer, Bernardo Mitre Ropero, Jesus Mora Pardina, Ingela Nygren, Susanne Petri, Mónica Povedano Panades, Francois Salachas, Pamela Shaw, Vincenzo Silani, Gert Staaf, Kirsten Svenstrup, Kevin Talbot, Ole-Bjørn Tysnes, Philip Van Damme, Anneke van der Kooi, Markus Weber, Patrick Weydt, Joachim Wolf, Orla Hardiman, Leonard H van den Berg

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 15%
Student > Bachelor 11 12%
Student > Master 10 11%
Student > Doctoral Student 8 9%
Other 7 8%
Other 21 24%
Unknown 19 21%
Readers by discipline Count As %
Medicine and Dentistry 15 17%
Biochemistry, Genetics and Molecular Biology 13 15%
Neuroscience 11 12%
Nursing and Health Professions 5 6%
Agricultural and Biological Sciences 5 6%
Other 11 12%
Unknown 29 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2023.
All research outputs
#1,086,883
of 26,017,215 outputs
Outputs from Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
#34
of 1,115 outputs
Outputs of similar age
#22,146
of 334,345 outputs
Outputs of similar age from Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
#2
of 28 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,115 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.